These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 16005519)

  • 1. 5-HT6 receptors: a novel target for cognitive enhancement.
    Mitchell ES; Neumaier JF
    Pharmacol Ther; 2005 Dec; 108(3):320-33. PubMed ID: 16005519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's disease.
    Geldenhuys WJ; Van der Schyf CJ
    Expert Rev Neurother; 2009 Jul; 9(7):1073-85. PubMed ID: 19589055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive dysfunction in neuropsychiatric disorders: selected serotonin receptor subtypes as therapeutic targets.
    Terry AV; Buccafusco JJ; Wilson C
    Behav Brain Res; 2008 Dec; 195(1):30-8. PubMed ID: 18241938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT(7) receptors in the modulation of cognitive processes.
    Cifariello A; Pompili A; Gasbarri A
    Behav Brain Res; 2008 Dec; 195(1):171-9. PubMed ID: 18243350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 5-HT6 antagonists, Ro-4368554 and SB-258585, in tests used for the detection of cognitive enhancement and antipsychotic-like activity.
    Gravius A; Laszy J; Pietraszek M; Sághy K; Nagel J; Chambon C; Wegener N; Valastro B; Danysz W; Gyertyán I
    Behav Pharmacol; 2011 Apr; 22(2):122-35. PubMed ID: 21301322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release.
    Marcos B; Gil-Bea FJ; Hirst WD; García-Alloza M; Ramírez MJ
    Eur J Neurosci; 2006 Sep; 24(5):1299-306. PubMed ID: 16987217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs.
    Millan MJ; Dekeyne A; Gobert A; Brocco M; Mannoury la Cour C; Ortuno JC; Watson D; Fone KCF
    Neuropharmacology; 2020 Oct; 177():108099. PubMed ID: 32525060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT6 receptor memory and amnesia: behavioral pharmacology--learning and memory processes.
    Meneses A; Pérez-García G; Ponce-Lopez T; Castillo C
    Int Rev Neurobiol; 2011; 96():27-47. PubMed ID: 21329783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders.
    Heal DJ; Smith SL; Fisas A; Codony X; Buschmann H
    Pharmacol Ther; 2008 Feb; 117(2):207-31. PubMed ID: 18068807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT6 receptor antagonists: prospects for the treatment of cognitive disorders including dementia.
    Johnson CN; Ahmed M; Miller ND
    Curr Opin Drug Discov Devel; 2008 Sep; 11(5):642-54. PubMed ID: 18729016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of 5-HT(1A) receptors in learning and memory.
    Ogren SO; Eriksson TM; Elvander-Tottie E; D'Addario C; Ekström JC; Svenningsson P; Meister B; Kehr J; Stiedl O
    Behav Brain Res; 2008 Dec; 195(1):54-77. PubMed ID: 18394726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics.
    Sumiyoshi T; Bubenikova-Valesova V; Horacek J; Bert B
    Adv Ther; 2008 Oct; 25(10):1037-56. PubMed ID: 18839076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memory formation and memory alterations: 5-HT6 and 5-HT7 receptors, novel alternative.
    Meneses A
    Rev Neurosci; 2014; 25(3):325-56. PubMed ID: 24698823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of the 5-HT
    de Jong IEM; Mørk A
    Neuropharmacology; 2017 Oct; 125():50-63. PubMed ID: 28711518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actions of novel agonists, antagonists and antipsychotic agents at recombinant rat 5-HT6 receptors: a comparative study of coupling to G alpha s.
    Dupuis DS; Mannoury la Cour C; Chaput C; Verrièle L; Lavielle G; Millan MJ
    Eur J Pharmacol; 2008 Jul; 588(2-3):170-7. PubMed ID: 18511034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel series of 3-piperidinyl-5-sulfonylindazoles as potent 5-HT6 ligands.
    Liu KG; Lo JR; Comery TA; Zhang GM; Zhang JY; Kowal DM; Smith DL; Di L; Kerns EH; Schechter LE; Robichaud AJ
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3214-6. PubMed ID: 19433358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of social isolation in the rat on serotonergic function and memory--relevance to models of schizophrenia and the role of 5-HT₆ receptors.
    Marsden CA; King MV; Fone KC
    Neuropharmacology; 2011 Sep; 61(3):400-7. PubMed ID: 21414329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive function and social abilities in patients with schizophrenia: relationship with atypical antipsychotics.
    Tyson PJ; Laws KR; Flowers KA; Tyson A; Mortimer AM
    Psychiatry Clin Neurosci; 2006 Aug; 60(4):473-9. PubMed ID: 16884450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease.
    Benhamú B; Martín-Fontecha M; Vázquez-Villa H; Pardo L; López-Rodríguez ML
    J Med Chem; 2014 Sep; 57(17):7160-81. PubMed ID: 24850589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin/dopamine interaction in learning.
    Olvera-Cortés ME; Anguiano-Rodríguez P; López-Vázquez MA; Alfaro JM
    Prog Brain Res; 2008; 172():567-602. PubMed ID: 18772051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.